Skip to main content
. 2016 Feb 2;7(11):12525–12536. doi: 10.18632/oncotarget.7123

Table 1. Quality criteria for the included studies*.

Quality parameter Score
2 1 0
Study design Cohort study or nested case-control study Incidence case-control study. Prevalence case-control study -
No. of case subjects >100 50-100 <50
Source of population Community-based or from two or more countries ≥2 hospitals 1 hospitals
Mutation detection method DNA direct sequencing Innogenetics line-probe assay Single-strand conformation polymorphism; Mass spectrometer
Matching of case and control subjects
Confounder group 1 Age and sex Age or sex None
Confounder group 2 HBeAg status and HBV genotype HBeAg status or HBV genotype None
*

-, designs other than cohort or nested, incidence, or prevalence case-control not included in meta-analysis; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus.